---
title: "Cathay Biotech: Accumulated over 10 million spent on share repurchase for incentives"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/260388723.md"
description: "Shanghai Cathay Biotech Co., Ltd. announced the progress of its share repurchase. According to the plan approved by the board of directors, the repurchase amount is expected to be between 10 million and 20 million yuan, mainly for employee stock ownership plans or equity incentives. As of September 30, 2025, the company has repurchased 230,366 shares, accounting for 0.0319% of the total share capital, with a cumulative repurchase amount of 10,497,716.71 yuan, and the repurchase price ranged from 44.08 yuan to 53.40 yuan. The company will continue to promote the repurchase and disclose relevant information in a timely manner"
datetime: "2025-10-09T07:35:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/260388723.md)
  - [en](https://longbridge.com/en/news/260388723.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/260388723.md)
generator: "portal-rs"
---

# Cathay Biotech: Accumulated over 10 million spent on share repurchase for incentives

Shanghai Cathay Biotech Co., Ltd. announced the progress of its share repurchase. The repurchase was proposed by the original controlling shareholder and was approved by the board of directors on October 21, 2024. The implementation period is from October 21, 2024, to October 20, 2025, with an expected repurchase amount of 10 million to 20 million yuan, intended for the employee stock ownership plan or equity incentive. As of September 30, 2025, the company has cumulatively repurchased 230,366 shares, accounting for 0.0319% of the total share capital, with a cumulative repurchase amount of 10,497,716.71 yuan, and the actual repurchase price range is 44.08 yuan/share - 53.40 yuan/share. The company will continue to promote the repurchase in accordance with regulations and disclose information in a timely manner

### Related Stocks

- [688065.CN](https://longbridge.com/en/quote/688065.CN.md)

## Related News & Research

- [Biocytogen Pharmaceuticals announces extraordinary general meeting](https://longbridge.com/en/news/297148979.md)
- [Fosun turns page after property writedowns, shifts focus back to growth](https://longbridge.com/en/news/297240299.md)
- [Football-NFL eyes expansion in Japan as international games reach record high](https://longbridge.com/en/news/297356333.md)
- [DAZN secures Sub-Saharan Africa rights for all LaLiga matches through 2029](https://longbridge.com/en/news/297363619.md)
- [My Mountain Mover Recognized Among the 2026 Inc. 5000 Fastest-Growing U.S. Companies](https://longbridge.com/en/news/297087696.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**